1. Home
  2. BFRI vs LRE Comparison

BFRI vs LRE Comparison

Compare BFRI & LRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biofrontera Inc.

BFRI

Biofrontera Inc.

HOLD

Current Price

$1.42

Market Cap

16.3M

Sector

Health Care

ML Signal

HOLD

Logo Lead Real Estate Co. Ltd

LRE

Lead Real Estate Co. Ltd

N/A

Current Price

$1.31

Market Cap

17.9M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
BFRI
LRE
Founded
1997
2001
Country
United States
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3M
17.9M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
BFRI
LRE
Price
$1.42
$1.31
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$2.75
N/A
AVG Volume (30 Days)
537.6K
7.6K
Earning Date
05-13-2026
07-30-2015
Dividend Yield
N/A
N/A
EPS Growth
67.70
N/A
EPS
N/A
N/A
Revenue
$41,705,000.00
N/A
Revenue This Year
$14.36
N/A
Revenue Next Year
$16.98
N/A
P/E Ratio
N/A
$3.16
Revenue Growth
11.75
N/A
52 Week Low
$0.57
$1.00
52 Week High
$1.52
$2.86

Technical Indicators

Market Signals
Indicator
BFRI
LRE
Relative Strength Index (RSI) 70.12 48.51
Support Level $0.77 $1.20
Resistance Level N/A $1.37
Average True Range (ATR) 0.09 0.06
MACD 0.02 -0.00
Stochastic Oscillator 71.62 45.83

Price Performance

Historical Comparison
BFRI
LRE

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.

About LRE Lead Real Estate Co. Ltd

Lead Real Estate Co Ltd operates as a developer of luxury residential properties, including single-family homes and condominiums, across Tokyo, Kanagawa Prefecture, and Sapporo. The company also operates hotels in Tokyo and leases apartment units to individual customers in Japan and Dallas, Texas. Its revenue is predominantly generated from developing and selling single-family homes and condominiums, hotel operations, and residential leasing. The company's sole operating segment is real estate sales. Geographically, it derives revenue from Japan.

Share on Social Networks: